vimarsana.com
Home
Live Updates
New preclinical data on the antifibrotic effects of tasquini
New preclinical data on the antifibrotic effects of tasquini
New preclinical data on the antifibrotic effects of tasquinimod in myelofibrosis to be presented at EHA 2023
Lund, May 11 2023 – Active Biotech announces today that new data on the mechanisms by which tasquinimod ameliorates bone marrow fibrosis in a murine model of myelofibrosis will be presented in... | May 11, 2023
Related Keywords
,
Active Biotech Ab Publ Stock Exchange ,
News ,
Information ,
Press Release ,
Bay ,
1 ,
023 ,
Ctive ,
Biotech ,
Nnounces ,
Oday ,
Hat ,
Few ,
Data ,
N ,
The ,
Mechanisms ,
Y ,
Which ,
Asquinimod ,
Ameliorates ,
One ,
Arrow ,
Ibrosis ,
Urine ,
Model ,
F ,
Myelofibrosis ,
Hill ,
He ,
Resented Acti Se0001137985 ,